Stock BVAXF BIOVAXYS TECHNOLOGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages BioVaxys Technology Corp. OTC Markets

Equities

BVAXF

CA09076M1014

Delayed OTC Markets
Other stock markets
 17:44:47 16/07/2024 BST 		5-day change 1st Jan Change
0.0479 USD -7.71% Intraday chart for BioVaxys Technology Corp. -8.76% +16.83%
07-10 BioVaxys Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
07-10 BioVaxys Technology Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioVaxys Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
BioVaxys Technology Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024
BioVaxys Technology Corp. Reports Earnings Results for the Full Year Ended October 31, 2023
Biovaxys Technology Corp. Delays to File Its Interim Financial Statements for the Three Months Ended January 31, 2024
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage
BioVaxys Technology Plans Private Placement; Down 5.9%
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
BioVaxys Technology Corp. Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications
BioVaxys Technology Corp. and Procare Health Agree to Termination of USA Distribution Agreement for Papilocare and Immunocaps
BioVaxys Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
BioVaxys Technology Corp. and The Ohio State University Extend Research Collaboration
BioVaxys Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
10402588 BC Ltd acquired TAETSoftware Corp.
Biovaxys Technology Corp. Announces Corporate Secretary Changes
Biovaxys Technology Corp. Announces Management Changes
BioVaxys Technology Corp. Reports Earnings Results for the First Quarter Ended January 31, 2023
BioVaxys Technology Corp. acquired TAETSoftware Corp for CAD 1.9 million.
BioVaxys Technology Corp. Reports Earnings Results for the Full Year Ended October 31, 2022
BioVaxys Technology Corp. Auditor Raises 'Going Concern' Doubt
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOV Stock
  4. BVAXF Stock
  5. News BioVaxys Technology Corp.
  6. Other languages